Seniedo, Briah Amari V.

HRN: 21-35-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/30/2022
09/06/2022
IV
75mg
Q24h
Uti
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes